1. Home
  2. AISP vs IMUX Comparison

AISP vs IMUX Comparison

Compare AISP & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airship AI Holdings Inc.

AISP

Airship AI Holdings Inc.

HOLD

Current Price

$2.29

Market Cap

90.4M

Sector

Finance

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$1.16

Market Cap

75.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AISP
IMUX
Founded
2006
2016
Country
United States
United States
Employees
63
66
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.4M
75.2M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
AISP
IMUX
Price
$2.29
$1.16
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$4.25
AVG Volume (30 Days)
383.8K
3.0M
Earning Date
02-17-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$222.88
N/A
Revenue Next Year
$5.36
N/A
P/E Ratio
$3.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.36
$0.51
52 Week High
$7.20
$1.51

Technical Indicators

Market Signals
Indicator
AISP
IMUX
Relative Strength Index (RSI) 34.98 55.82
Support Level N/A $0.64
Resistance Level $2.85 $1.17
Average True Range (ATR) 0.17 0.13
MACD -0.02 -0.02
Stochastic Oscillator 11.76 33.55

Price Performance

Historical Comparison
AISP
IMUX

About AISP Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture. Airship AI's software allows customers to view structured data both in real-time as well as to conduct searches on the structured data at a later point in time.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: